ASCO GU 2021: Outcomes of first-line immunotherapy combinations in metastatic kidney cancer
Combinations of immunotherapy drugs nivolumab plus ipilimumab and immunotherapy/vascular endothelial [...]
Combinations of immunotherapy drugs nivolumab plus ipilimumab and immunotherapy/vascular endothelial [...]
Results from the phase 3 CLEAR study, presented at the [...]
In a small phase 2 study presented at the virtual [...]
Results of a retrospective study presented during the 2021 American [...]
Brain metastases resulting from the spread of renal cell carcinoma [...]
The past couple of years has seen a number of [...]
The microbes in the gut (the gut microbiome) are a [...]
The Food and Drug Administration (FDA) in the United States has [...]
In this study, the researchers looked at the interaction between [...]
A large review of the data showed that cancer specific [...]